Global In Vitro Diagnostics (IVD) Products and Test Market Growth (Status and Outlook) 2023-2029

Global In Vitro Diagnostics (IVD) Products and Test Market Growth (Status and Outlook) 2023-2029

LPI (LP Information)' newest research report, the “In Vitro Diagnostics (IVD) Products and Test Industry Forecast” looks at past sales and reviews total world In Vitro Diagnostics (IVD) Products and Test sales in 2022, providing a comprehensive analysis by region and market sector of projected In Vitro Diagnostics (IVD) Products and Test sales for 2023 through 2029. With In Vitro Diagnostics (IVD) Products and Test sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world In Vitro Diagnostics (IVD) Products and Test industry.

This Insight Report provides a comprehensive analysis of the global In Vitro Diagnostics (IVD) Products and Test landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on In Vitro Diagnostics (IVD) Products and Test portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global In Vitro Diagnostics (IVD) Products and Test market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for In Vitro Diagnostics (IVD) Products and Test and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global In Vitro Diagnostics (IVD) Products and Test.

The global In Vitro Diagnostics (IVD) Products and Test market size is projected to grow from US$ 79300 million in 2022 to US$ 124950 million in 2029; it is expected to grow at a CAGR of 6.7% from 2023 to 2029.

United States market for In Vitro Diagnostics (IVD) Products and Test is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for In Vitro Diagnostics (IVD) Products and Test is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for In Vitro Diagnostics (IVD) Products and Test is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key In Vitro Diagnostics (IVD) Products and Test players cover Abbott Laboratories(US), Becton Dickinson Company(US), bioMerieux SA(France), F. Hoffmann-La Roche Ltd.(Switzerland), Siemens Healthcare(Germany), Alere Inc(US), Beckman Coulter, Inc.(US), Bio-Rad Laboratories(US) and Hologic(US), etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of In Vitro Diagnostics (IVD) Products and Test market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
General Chemistries
Critical Care
Urinalysis
Analyzers Blood Gases
Workstations
Others

Segmentation by application
Molecular Diagnostics
Clinical Chemistry
Diabetes and Glucose Testing
Immunochemistry
Hematology
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott Laboratories(US)
Becton Dickinson Company(US)
bioMerieux SA(France)
F. Hoffmann-La Roche Ltd.(Switzerland)
Siemens Healthcare(Germany)
Alere Inc(US)
Beckman Coulter, Inc.(US)
Bio-Rad Laboratories(US)
Hologic(US)
Ortho Clinical Diagnostics(US)
Roche Diagnostics(US)

Please note: The report will take approximately 2 business days to prepare and deliver.